MA30473B1 - Procede de preparation de formes polymorphiques d'hydrogenosulfate de clopidogrel. - Google Patents

Procede de preparation de formes polymorphiques d'hydrogenosulfate de clopidogrel.

Info

Publication number
MA30473B1
MA30473B1 MA31390A MA31390A MA30473B1 MA 30473 B1 MA30473 B1 MA 30473B1 MA 31390 A MA31390 A MA 31390A MA 31390 A MA31390 A MA 31390A MA 30473 B1 MA30473 B1 MA 30473B1
Authority
MA
Morocco
Prior art keywords
clopidogrel
preparation
hydrogenosulfate
polymorphic forms
hydrogen sulfate
Prior art date
Application number
MA31390A
Other languages
English (en)
Inventor
Rahul Saxena
Naresh Kumar Verma
Chidambaram Venkateswaran Srinivasan
Lalit Wadhwa
Original Assignee
Ind Swift Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Swift Lab Ltd filed Critical Ind Swift Lab Ltd
Publication of MA30473B1 publication Critical patent/MA30473B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne un nouvel procédé de préparation de la forme I et d'une forme amorphe d'hydrogénosulfate de clopidogrel, à savoir méthyle (+)-(S)-(alpha)-(o-chlorophényle)-6,7-dihydrothieno [3,2-c] pyridine-5(4H)-acétate hydrogénosulfate (hydrogénosufate de clopidogrel) de la formule (I).
MA31390A 2006-04-27 2008-11-20 Procede de preparation de formes polymorphiques d'hydrogenosulfate de clopidogrel. MA30473B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1075DE2006 2006-04-27
IN1794DE2006 2006-08-08

Publications (1)

Publication Number Publication Date
MA30473B1 true MA30473B1 (fr) 2009-06-01

Family

ID=38655911

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31390A MA30473B1 (fr) 2006-04-27 2008-11-20 Procede de preparation de formes polymorphiques d'hydrogenosulfate de clopidogrel.

Country Status (10)

Country Link
US (1) US20090099363A1 (fr)
EP (1) EP2012781A2 (fr)
JP (1) JP2009543759A (fr)
KR (1) KR20090013794A (fr)
CN (1) CN102014899A (fr)
CA (1) CA2650471A1 (fr)
MA (1) MA30473B1 (fr)
MX (1) MX2008013724A (fr)
RU (1) RU2008146758A (fr)
WO (1) WO2007125544A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090247569A1 (en) * 2006-08-03 2009-10-01 Claude Singer Process for Preparing Clopidogrel Bisulphate
PL382055A1 (pl) * 2007-03-23 2008-09-29 Koźluk Tomasz Nobilus Ent Sposób wytwarzania formy krystalicznej 1 wodorosiarczanu klopidogrelu
EP2350094A1 (fr) * 2008-10-20 2011-08-03 Ranbaxy Laboratories Limited Procédé de préparation de la forme 1 de l hydrogénosulfate de clopidogrel
CN102199160B (zh) * 2011-03-22 2016-06-22 浙江华海药业股份有限公司 一种制备ⅰ型硫酸氢氯吡格雷的方法
CN102443010A (zh) * 2011-11-05 2012-05-09 江南大学 一种无定形氯吡格雷硫酸氢盐的制备方法
CN102432625A (zh) * 2011-11-05 2012-05-02 江南大学 一种制备高纯度i型氯吡格雷硫酸氢盐的结晶方法
CN102875568B (zh) * 2012-09-06 2015-12-09 苏州晶云药物科技有限公司 制备(+)-(s)-氯吡格雷硫酸氢盐纯晶型i的方法
WO2014118802A1 (fr) * 2013-01-31 2014-08-07 Pharmazell Gmbh Procédé amélioré pour la préparation de bisulfate de clopidogrel de forme i
CN105218559A (zh) * 2015-10-21 2016-01-06 云南省药物研究所 一种稳定的非晶态硫酸氢氯吡格雷复合物
CN113121559B (zh) * 2019-12-31 2023-08-29 惠州信立泰药业有限公司 一种高堆密度的ii型硫酸氢氯吡格雷球形结晶及制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2664276B1 (fr) * 1990-07-04 1992-10-23 Sanofi Sa Derive thienyl-2 glycidique, son procede de preparation et son utilisation comme intermediaire de synthese.
HU222283B1 (hu) * 1997-05-13 2003-05-28 Sanofi-Synthelabo Eljárás tieno[3,2-c]piridin-származékok előállítására
HU225504B1 (en) * 1997-05-13 2007-01-29 Sanofi Aventis Novel halophenyl-(2-(2-thienyl)-ethylamino)-acetonitriles and process for producing them
HU225503B1 (en) * 1997-05-13 2007-01-29 Sanofi Aventis Novel 2-(2-halophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides and process for producing them
FR2779726B1 (fr) * 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
US6767913B2 (en) * 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) * 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
AU2003285841A1 (en) * 2002-11-28 2004-06-18 Anpharm Przedsiebiorstwo Farmaceutyczne S.A. A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate
WO2004081015A1 (fr) * 2003-03-10 2004-09-23 Hetero Drugs Limited Hydrogene sulfate de clopidogrel amorphe
US7872019B2 (en) * 2003-03-12 2011-01-18 Cadila Healthcare Limited Polymorphs and amorphous form of (S)-(+)-clopidogrel bisulfate
US20060047121A1 (en) * 2004-09-01 2006-03-02 Sawant Kamlesh D Novel process for preparation of clopidogrel bisulfate polymorph - Form I
US7446200B2 (en) * 2004-10-04 2008-11-04 Usv, Ltd. Rapid resolution process of clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph-form I
US7772398B2 (en) * 2005-03-11 2010-08-10 Dr. Reddy's Laboratories, Inc. Process for making crystalline form I of clopidogrel hydrogen sulphate
US20070191609A1 (en) * 2006-02-13 2007-08-16 Lee Pharma Limited Process for preparation of clopidogrel bisulphate form-1
US20070225320A1 (en) * 2006-03-27 2007-09-27 Eswaraiah Sajja Process for preparing clopidogrel
US20080188663A1 (en) * 2007-01-29 2008-08-07 Ashok Kumar Process for the preparation of crystalline clopidogrel hydrogen sulphate Form I

Also Published As

Publication number Publication date
MX2008013724A (es) 2009-06-19
CA2650471A1 (fr) 2007-11-08
EP2012781A2 (fr) 2009-01-14
US20090099363A1 (en) 2009-04-16
RU2008146758A (ru) 2010-06-10
KR20090013794A (ko) 2009-02-05
JP2009543759A (ja) 2009-12-10
WO2007125544A2 (fr) 2007-11-08
WO2007125544A3 (fr) 2016-06-09
CN102014899A (zh) 2011-04-13

Similar Documents

Publication Publication Date Title
MA30473B1 (fr) Procede de preparation de formes polymorphiques d'hydrogenosulfate de clopidogrel.
SI1513846T1 (sl) Postopek za pripravo olanzapina form I
EP1651646A4 (fr) Procede nouveau de preparation de bisulfate de (+)-(s)-clopidogrel de forme i
DK1620439T3 (da) Hidtil ukendte polymorfer af olanzapinhydrochlorid
MA28588B1 (fr) Formes polymorphes d'hydrobromure d'acetate de methyl(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h) acetate hydrobromide, hydrobromure de clopidrogel
SI1513845T1 (sl) Postopek za pripravo olanzapina in intermediat zanj
EA200701770A1 (ru) СПОСОБ РАЦЕМИЗАЦИИ R(-) ИЗОМЕРА МЕТИЛОВОГО ЭФИРА (2-ХЛОРФЕНИЛ)-6,7-ДИГИДРОТИЕНО[3,2-c]ПИРИДИН-5(4Н)-УКСУСНОЙ КИСЛОТЫ
HU0600194D0 (en) Process for producing (s)-(+)-methyl-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h)-acetate hidrogen sulfate polimorph i
DK1501838T3 (da) Fremgangsmåde til fremstilling af clopidogrel
WO2007087555A3 (fr) Novel polymorph e of olanzapine and preparation of anhydrous non-solvated crystaline polymorphic form i of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2,3-b][1,5]benzodiazepine (olansapine form i) from the polymorphic olanzapine form e
WO2007032023A3 (fr) Procede de preparation d'ester methylique de l'acide methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h)-acetique ou de sels dudit acide ayant une purete chirale elevee et produits ainsi obtenus
NO20073165L (no) Fremgangsmate for fremstillingen av N-demetylolanzapin
EA201001278A1 (ru) Способ получения оланзапина
UA86772C2 (en) Process for the preparation of the polymorph form of methyl (s)-(+)-(2-chlorophenyl)-2-(6,7-dihydro-4h-thieno[3,2-c]pyridine-5-yl-acetate hydrogensulfate
HUP0700809A2 (en) Racemisation process for producing methyl (r,s)-(+)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-acetate hydrogene sulfate intermediate
WO2005003138A3 (fr) Procede de fabrication d'une forme amorphe d'un medicament inhibant l'agregation plaquettaire
DE602007012121D1 (de) Verbessertes verfahren zur herstellung von clopidogrel und pharmazeutisch unbedenklichen salzen davon
WO2008108742A3 (fr) Formes polymorphes de bromhydrate de clopidogrel
FR2909670B1 (fr) Derive fluore de quinoleine-2(1h)-one,son procede de preparation et son utilisation comme intermediaire de synthese
PL380849A1 (pl) Krystaliczna postać racemicznego -(2-chlorofenylo)-6,7-dihydrotieno[3,2-c]pirydylo-5(4H)-octanu metylu, sposób jej wytwarzania i zastosowanie